Xeris Biopharma Holdings, Inc.

NEW YORK STATE COMMON RETIREMENT FUND XERS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

43,422

Value ($000)

341

Weight

0.0%

2022 Q2 - 2025 Q4 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	341	0.0%	43,422	12/31/2025
2025 Q3	11/3/2025	353	0.0%	43,422	9/30/2025
2025 Q2	10/8/2025	203	0.0%	43,422	6/30/2025
2025 Q1	10/8/2025	238	0.0%	43,422	3/31/2025
2024 Q4	10/8/2025	77	0.0%	22,822	12/31/2024
2024 Q3	10/8/2025	65	0.0%	22,822	9/30/2024
2024 Q2	10/8/2025	51	0.0%	22,822	6/30/2024
2024 Q1	10/8/2025	50	0.0%	22,784	3/31/2024
2023 Q4	10/8/2025	54	0.0%	22,875	12/31/2023
2023 Q3	10/8/2025	43	0.0%	23,135	9/30/2023
2023 Q2	10/8/2025	59	0.0%	22,672	6/30/2023
2023 Q1	10/8/2025	37	0.0%	22,787	3/31/2023
2022 Q4	10/8/2025	123	0.0%	92,487	12/31/2022
2022 Q3	11/8/2022	144	0.0%	92,500	9/30/2022
2022 Q2	8/4/2022	141	0.0%	91,400	6/30/2022